Promethazine Hydrochloride Injection
FDA Label NDC 0641-1495

54 label sections · Submitted to the FDA by Hikma Pharmaceuticals Usa Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hikma Pharmaceuticals Usa Inc. for the product Promethazine Hydrochloride (NDC 0641-1495). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings: respiratory depression in pediatrics and severe tissue injury including gangrene, description, clinical pharmacology, indications and usage, contraindications, pediatrics, other, severe tissue injury, including gangrene, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.